Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-01

Clinical Trial Update: Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of the inhaled combination of fluticasone furoate and vilanterol for asthma in adolescents and adults of Asian …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BREO ELLIPTA (fluticasone furoate and vilanterol trifenatate)
  • Fluticasone Furoate (fluticasone furoate)
  • vilanterol trifenatate (vilanterol trifenatate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2014-04-01